What's New

Last Posted: May 18, 2023

• Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome.
  Po-Han Lin et al. J Gynecol Oncol 2023
• Pancreatic Cancer Screening for At-risk Individuals (Pancreas Scan Study): Yield, Harms and Outcomes from a Prospective Multi-Center Study.
  Ishani Shah et al. Am J Gastroenterol 2023
• Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer.
  T M Reissig et al. ESMO Open 2023 8(3) 101539
• A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories.
  Davide Placido et al. Nat Med 2023 5
• Familial aggregation of early-onset cancers in early-onset breast cancer families.
  Jasmiina N J Rantala et al. Int J Cancer
• Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?
  Alexandra M Roch et al. J Surg Oncol
• Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area.
  Valentina Zampiga et al. Cancers (Basel) 2023 15(7)
• Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma.
  Kum Hei Ryu et al. Cancer research and treatment 2023
• IPMN-LEARN: A linear support vector machine learning model for predicting low-grade intraductal papillary mucinous neoplasms.
  Yasmin Genevieve Hernandez-Barco et al. Annals of hepato-biliary-pancreatic surgery 2023
• Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients with Pancreatic Cancer or Suspected Related Hereditary Syndromes: Historical Prospective Analysis.
  Arianna Dal Buono et al. Cancers 2023 15(6)

More